The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Clin Cancer Res. 2019 05 01; 25(9):2745-2754.

View in: PubMed

subject areas

Aged
Animals
Antigens, Tumor-Associated, Carbohydrate
Biomarkers, Tumor
CA-19-9 Antigen
Carcinoma, Pancreatic Ductal
Case-Control Studies
Female
Follow-Up Studies
Humans
Male
Mice
Middle Aged
N-Acetylneuraminic Acid
Pancreatic Neoplasms
Prognosis
Tumor Cells, Cultured
Xenograft Model Antitumor Assays

authors with profiles

Richard R. Drake